BMO Capital Markets is looking to enhance its Equity Research department by hiring a Senior Biotechnology Research Analyst to lead coverage of small and mid-cap oncology companies, providing differentiated and actionable investment theses to clients.
Requirements
- Ability to analyze clinical trial design and data across early and late-stage oncology trials (including dose escalation, dose-expansion, PFS/OS and response endpoints, statistical powering, and drug safety)
- Deep understanding of the drug regulatory and reimbursement environment across geographies
- Strong financial modeling and valuation skills, with a focus on forecasting early- and mid-stage oncology companies
- Ability to assess viability, competitive positioning, and likelihood of success of pre-clinical and clinical-stage oncology assets
- FINRA Series 7, 63, 86 & 87 licenses
- Expertise in oncology and the biotechnology sector
- Deep relationships across public and private oncology companies; in addition to key opinion leaders and expert physicians in oncology
Responsibilities
- Lead coverage of small and mid-cap oncology companies, across modalities and developmental stages
- Ideate and execute on production of differentiated and timely research; provide a unique point of view on the oncology and broader biotechnology sector
- Build and maintain robust financial and probability-adjusted revenue/pipeline models for oncology companies
- Present well supported investment recommendations for covered companies, including ratings and target prices
- Ability to analyze clinical trial design and data across early and late-stage oncology trials (including dose escalation, dose-expansion, PFS/OS and response endpoints, statistical powering, and drug safety)
- Monitoring of the competitive landscape as it relates to covered companies
- Independently vet and assess companies for potential transactions underwritten by BMO’s investment bank, including IPOs and secondary equity raises
Other
- The individual serves as a trusted advisor to internal and external stakeholders.
- The ideal candidate can translate scientific analysis and clinical data into differentiated and actionable investment theses for buy-side clients and other key stakeholders.
- A combination of exceptional writing skills, technical knowledge and skills in equity research, finance/accounting, demonstrated through relevant work and educational experiences.
- Candidates must have a clear and proven track record of achievement throughout their education and career.
- Proven ability to lead a team and develop associate analysts
